Steven W. Spector
2016
In 2016, Steven W. Spector earned a total compensation of $1.5M as Executive Vice President, General Counsel and Secretary at Arena Pharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,904 |
|---|---|
| Option Awards | $844,810 |
| Salary | $431,600 |
| Other | $16,800 |
| Total | $1,483,114 |
Spector received $844.8K in option awards, accounting for 57% of the total pay in 2016.
Spector also received $189.9K in non-equity incentive plan, $431.6K in salary and $16.8K in other compensation.
Rankings
In 2016, Steven W. Spector's compensation ranked 6,300th out of 14,075 executives tracked by ExecPay. In other words, Spector earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,300 out of 14,075 | 55th |
Division Manufacturing | 2,315 out of 5,489 | 58th |
Major group Chemicals And Allied Products | 759 out of 1,895 | 60th |
Industry group Drugs | 575 out of 1,538 | 63rd |
Industry Pharmaceutical Preparations | 453 out of 1,176 | 62nd |
Source: SEC filing on April 28, 2017.
Spector's colleagues
We found six more compensation records of executives who worked with Steven W. Spector at Arena Pharmaceuticals in 2016.
2016
Amit Munshi
Arena Pharmaceuticals
Chief Executive Officer
2016
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2016
Kevin Lind
Arena Pharmaceuticals
Chief Financial Officer
2016
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
2016
Vincent Aurentz
Arena Pharmaceuticals
Executive Vice President and Chief Business Officer
2016
Harry Hixson
Arena Pharmaceuticals